David Nochlin

8.8k citations

92 papers · 6.6k indexed · h-index 45

Impact in

Physiology top 0.2%
- Alzheimer's disease research and treatments
Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism

Papers in ⓘ

Physiology 49
- Alzheimer's disease research and treatments 47
Molecular Biology 45
- Prion Diseases and Protein Misfolding 14
- Amyloidosis: Diagnosis, Treatment, Outcomes 13

Co-authors: Thomas D. Bird (31 shared papers)Alan D. Snow (14 shared papers)S. M. Sumi (24 shared papers)Koji Kimata (5 shared papers)Gerard D. Schellenberg (12 shared papers)Thomas N. Wight (9 shared papers)Parvoneh Poorkaj (7 shared papers)H Mar (5 shared papers)
Journals: Annals of Neurology (10 papers)Neurology (6 papers)Alzheimer Disease & Associated Disorders (5 papers)Journal of Neuropathology & Experimental Neurology (4 papers)Acta Neuropathologica (4 papers)
Partner nations: United States Japan Canada

In The Last Decade

David Nochlin

91 papers receiving 6.4k citations

Peers

Countries citing papers authored by David Nochlin

Since Specialization

Citations

This map shows the geographic impact of David Nochlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nochlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nochlin more than expected).

Fields of papers citing papers by David Nochlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Nochlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nochlin. The network helps show where David Nochlin may publish in the future.

Co-authors

The 25 scholars most cited alongside David Nochlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Nochlin Line = papers co-authored together David Nochlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lewy Bodies Contain Altered α-Synuclein in Brains of Many Familial Alzheimer's Disease Patients with Mutations in Presenilin and Amyloid Precursor Protein Genes American Journal Of Pathology ·Carol F. Lippa, Hideo Fujiwara, David M. A. Mann, Benoit I. Giasson, Minami Baba, Marie L. Schmidt, Linda E. Nee, Brendan P. O’Connell, Dan A. Pollen, Peter St George‐Hyslop, Bernardino Ghetti, David Nochlin, Thomas D. Bird, Nigel J. Cairns, Virginia M.‐Y. Lee, Takeshi Iwatsubo, John Q. Trojanowski	1998	429
2	Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements Proceedings of the National Academy of Sciences ·Ian D’Souza, Parvoneh Poorkaj, Ming Hong, David Nochlin, Virginia M.‐Y. Lee, Thomas D. Bird, Gerard D. Schellenberg	1999	406
3	The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. PubMed ·Alan D. Snow, H Mar, David Nochlin, Koji Kimata, Masato Kato, S Suzuki, John M. Hassell, Thomas N. Wight	1988	362
4	Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series Journal of the American Geriatrics Society ·Alfredo Lim, Debby W. Tsuang, Walter A. Kukull, David Nochlin, James B. Leverenz, Wayne C. McCormick, Jim Bowen, Linda Teri, Jill C. Thompson, Elaine R. Peskind, Murray A. Raskind, Eric B. Larson	1999	302
5	Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system Brain and Development ·Harvey B. Sarnat, David Nochlin, Donald E. Born	1998	255
6	An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain Neuron ·Alan D. Snow, Raymond Sekiguchi, David Nochlin, Paul E. Fraser, Koji Kimata, Akihiro Mizutani, Mikio Arai, Wayne A. Schreier, David Morgan	1994	250
7	Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome Neurobiology of Aging ·Alan D. Snow, H Mar, David Nochlin, Raymond Sekiguchi, Koji Kimata, Y Koike, Thomas N. Wight	1990	214
8	The Number of Trait Loci in Late-Onset Alzheimer Disease The American Journal of Human Genetics ·E. Warwick Daw, Haydeh Payami, Ellen Nemens, David Nochlin, Thomas D. Bird, Gerard D. Schellenberg, Ellen M. Wijsman	2000	213
9	Missense Mutations in the Regulatory Domain of PKCγ: A New Mechanism for Dominant Nonepisodic Cerebellar Ataxia The American Journal of Human Genetics ·Dong-Hui Chen, Zoran Brkanac, Christophe L. M. J. Verlinde, Xiao-Jian Tan, Laura Bylenok, David Nochlin, Mark Matsushita, Hillary Lipe, John Wolff, Magali Fernandez, Patrick J. Cimino, D. Thomas Bird, Wendy H. Raskind	2003	174
10	Absence of Linkage of Chromosome 21q21 Markers to Familial Alzheimer's Disease Science ·Gerard D. Schellenberg, Thomas D. Bird, Ellen M. Wijsman, Deborah K. Moore, Michael Boehnke, Eileen Bryant, Thomas H. Lampe, David Nochlin, S. M. Sumi, Samir S. Deeb, Konrad Beyreuther, George M. Martin	1988	173
11	A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain ·Thomas D. Bird, David Nochlin, Parvoneh Poorkaj, Monique Cherrier, Jeffrey Kaye, Haydeh Payami, Elaine R. Peskind, Thomas H. Lampe, Ellen Nemens, Philip J. Boyer, (unknown)	1999	163
12	Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ₄₂₍₄₃₎ Annals of Neurology ·D.M.A. Mann, Takeshi Iwatsubo, N. J. Cairns, P. L. Lantos, David Nochlin, S. M. Sumi, Thomas D. Bird, Parvoneh Poorkaj, John Hardy, M. Hutton, Guy Prihar, Richard Crook, Martin N. Rossor, Matti Haltia	1996	155
13	Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. PubMed ·Alan D. Snow, Thomas N. Wight, David Nochlin, Y Koike, Koji Kimata, S. J. DeArmond, S. B. Prusiner	1990	141
14	Comparison of Postmortem Magnetic Resonance Imaging and Neuropathologic Findings in the Cerebral White Matter Archives of Neurology ·Scott T. Grafton, S. M. Sumi, Gary K. Stimac, Ellsworth C. Alvord, C M Shaw, David Nochlin	1991	139
15	Phenotypic heterogeneity in familial alzheimer's disease: A study of 24 kindreds Annals of Neurology ·Thomas D. Bird, S. M. Sumi, Ellen Nemens, David Nochlin, Gerard D. Schellenberg, Thomas H. Lampe, A. Dessa Sadovnick, Helena C. Chui, Gary W. Miner, J. R. Tinklenberg	1989	134
16	Frequency of Tau Gene Mutations in Familial and Sporadic Cases of Non-Alzheimer Dementia Archives of Neurology ·Parvoneh Poorkaj, Murray Grossman, Ellen J. Steinbart, Haydeh Payami, A. Dessa Sadovnick, David Nochlin, Takeshi Tabira, John Q. Trojanowski, Soo Borson, Douglas Galasko, Stephen G. Reich, Bruce Quinn, Gerard D. Schellenberg, Thomas D. Bird	2001	125
17	Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. Journal of Histochemistry & Cytochemistry ·Alan D. Snow, H Mar, David Nochlin, Hans Kresse, Thomas N. Wight	1992	121
18	Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. PubMed ·Alan D. Snow, Raymond Sekiguchi, David Nochlin, Rajesh N. Kalaria, Koji Kimata	1994	115
19	Clinical and Neuropathological Characteristics of Hippocampal Sclerosis Archives of Neurology ·James B. Leverenz, Christina M. Agustin, Debby W. Tsuang, Elaine R. Peskind, Steven D. Edland, David Nochlin, Lillian DiGiacomo, James D. Bowen, Wayne C. McCormick, Linda Teri, Murray A. Raskind, Walter A. Kukull, Eric B. Larson	2002	114
20	Lewy Body Pathology in Familial Alzheimer Disease Archives of Neurology ·James B. Leverenz, Mark A. Fishel, Elaine R. Peskind, Thomas J. Montine, David Nochlin, Ellen J. Steinbart, Murray A. Raskind, Gerard D. Schellenberg, Thomas D. Bird, Debby W. Tsuang	2006	100

About David Nochlin

David Nochlin is a scholar working on Physiology, Molecular Biology, Psychiatry and Mental health, Neurology and Cellular and Molecular Neuroscience, having authored 92 papers that have together received 6.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (47 papers), Dementia and Cognitive Impairment Research (17 papers), Prion Diseases and Protein Misfolding (14 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Parkinson's Disease Mechanisms and Treatments (9 papers), Nuclear Receptors and Signaling (6 papers), Proteoglycans and glycosaminoglycans research (5 papers) and Neurological diseases and metabolism (5 papers). The work is most often cited by research in Physiology (4.0k citations), Neurology (1.2k citations), Neurology (1.5k citations), Psychiatry and Mental health (1.2k citations) and Cellular and Molecular Neuroscience (1.2k citations). David Nochlin has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Thomas D. Bird, Alan D. Snow, S. M. Sumi, Koji Kimata, Gerard D. Schellenberg, Thomas N. Wight, Parvoneh Poorkaj, H Mar, Raymond Sekiguchi and Murray A. Raskind. Their work appears in journals such as Annals of Neurology, Neurology, Alzheimer Disease & Associated Disorders, Journal of Neuropathology & Experimental Neurology and Acta Neuropathologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact